Exelixis
EXEL
#1596
Rank
C$15.38 B
Marketcap
$54.97
Share price
-0.67%
Change (1 day)
81.72%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company